Iron shots after valve surgery: could they boost energy and walking ability?
NCT ID NCT07370688
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether giving iron infusions after a minimally invasive heart valve replacement (TAVI) helps patients with aortic stenosis and iron deficiency feel better and walk farther. About 402 older adults will be randomly assigned to receive iron or standard care. Researchers will measure quality of life and exercise capacity 24 weeks after the procedure.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ferric carboxymaltose (iron infusion)
- What this could lead to
- If it works, this could show that correcting iron deficiency after TAVI helps patients feel better and walk farther.
- What could go wrong
- This is a Phase 4 trial, but the benefit of iron in this setting is not proven. Some patients may not improve, and iron infusions carry rare risks like allergic reactions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC VALVE STENOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Erasmus University Medical Center
RECRUITINGRotterdam, South Holland, 3015 GD, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can better healthcare access save hearts after prison?
- Can lifestyle choices after a stroke extend life and prevent a second one?
- Could a simple health chat slash heart disease and cancer risk?
- One scan, many answers: can a new CT predict heart risks after stenting?
- Digital coaching aims to boost heart health in obesity
- Can a new device suck out deadly lung clots?